Likewise, PCC0208009, a potent IDO1 inhibitor, significantly synergised with TMZ to reduce subcutaneous GL2612 tumour growth in mice and improved survival in a C6 orthotopic rat model of glioma [28]. This evidence concerns the gene IDO1 and central nervous system cancer.